The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Postoperative Pain Therapeutics Market Research Report 2025
Synopsis
As the global healthcare space is seeing a palpable shift toward a 'value-based care' model, postoperative pain management is gaining its very own eminence.
The global Postoperative Pain Therapeutics market was valued at US$ 9864.9 million in 2023 and is anticipated to reach US$ 12140 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Postoperative Pain Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postoperative Pain Therapeutics.
Report Scope
The Postoperative Pain Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Postoperative Pain Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Postoperative Pain Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
Pacira BioSciences
Trevena
Heron Therapeutics
Pfizer
Teva Pharmaceutical Industries
Novartis
Camarus
Eli Lilly
Bayer AG
Segment by Type
Oral
Intramuscular
Intravenous
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Postoperative Pain Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Postoperative Pain Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
As the global healthcare space is seeing a palpable shift toward a 'value-based care' model, postoperative pain management is gaining its very own eminence.
The global Postoperative Pain Therapeutics market was valued at US$ 9864.9 million in 2023 and is anticipated to reach US$ 12140 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Postoperative Pain Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postoperative Pain Therapeutics.
Report Scope
The Postoperative Pain Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Postoperative Pain Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Postoperative Pain Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
Pacira BioSciences
Trevena
Heron Therapeutics
Pfizer
Teva Pharmaceutical Industries
Novartis
Camarus
Eli Lilly
Bayer AG
Segment by Type
Oral
Intramuscular
Intravenous
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Postoperative Pain Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Postoperative Pain Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Postoperative Pain Therapeutics Market Overview
1.1 Product Overview and Scope of Postoperative Pain Therapeutics
1.2 Postoperative Pain Therapeutics Segment by Type
1.2.1 Global Postoperative Pain Therapeutics Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Intramuscular
1.2.4 Intravenous
1.2.5 Others
1.3 Postoperative Pain Therapeutics Segment by Application
1.3.1 Global Postoperative Pain Therapeutics Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Postoperative Pain Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Postoperative Pain Therapeutics Revenue 2019-2030
1.4.2 Global Postoperative Pain Therapeutics Sales 2019-2030
1.4.3 Global Postoperative Pain Therapeutics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Postoperative Pain Therapeutics Market Competition by Manufacturers
2.1 Global Postoperative Pain Therapeutics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Postoperative Pain Therapeutics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Postoperative Pain Therapeutics Average Price by Manufacturers (2019-2024)
2.4 Global Postoperative Pain Therapeutics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Postoperative Pain Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Postoperative Pain Therapeutics, Product Type & Application
2.7 Postoperative Pain Therapeutics Market Competitive Situation and Trends
2.7.1 Postoperative Pain Therapeutics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Postoperative Pain Therapeutics Players Market Share by Revenue
2.7.3 Global Postoperative Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Postoperative Pain Therapeutics Retrospective Market Scenario by Region
3.1 Global Postoperative Pain Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Postoperative Pain Therapeutics Global Postoperative Pain Therapeutics Sales by Region: 2019-2030
3.2.1 Global Postoperative Pain Therapeutics Sales by Region: 2019-2024
3.2.2 Global Postoperative Pain Therapeutics Sales by Region: 2025-2030
3.3 Global Postoperative Pain Therapeutics Global Postoperative Pain Therapeutics Revenue by Region: 2019-2030
3.3.1 Global Postoperative Pain Therapeutics Revenue by Region: 2019-2024
3.3.2 Global Postoperative Pain Therapeutics Revenue by Region: 2025-2030
3.4 North America Postoperative Pain Therapeutics Market Facts & Figures by Country
3.4.1 North America Postoperative Pain Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Postoperative Pain Therapeutics Sales by Country (2019-2030)
3.4.3 North America Postoperative Pain Therapeutics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Postoperative Pain Therapeutics Market Facts & Figures by Country
3.5.1 Europe Postoperative Pain Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Postoperative Pain Therapeutics Sales by Country (2019-2030)
3.5.3 Europe Postoperative Pain Therapeutics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Postoperative Pain Therapeutics Market Facts & Figures by Country
3.6.1 Asia Pacific Postoperative Pain Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Postoperative Pain Therapeutics Sales by Country (2019-2030)
3.6.3 Asia Pacific Postoperative Pain Therapeutics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Postoperative Pain Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Postoperative Pain Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Postoperative Pain Therapeutics Sales by Country (2019-2030)
3.7.3 Latin America Postoperative Pain Therapeutics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Postoperative Pain Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Postoperative Pain Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Postoperative Pain Therapeutics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Postoperative Pain Therapeutics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Postoperative Pain Therapeutics Sales by Type (2019-2030)
4.1.1 Global Postoperative Pain Therapeutics Sales by Type (2019-2024)
4.1.2 Global Postoperative Pain Therapeutics Sales by Type (2025-2030)
4.1.3 Global Postoperative Pain Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Postoperative Pain Therapeutics Revenue by Type (2019-2030)
4.2.1 Global Postoperative Pain Therapeutics Revenue by Type (2019-2024)
4.2.2 Global Postoperative Pain Therapeutics Revenue by Type (2025-2030)
4.2.3 Global Postoperative Pain Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Postoperative Pain Therapeutics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Postoperative Pain Therapeutics Sales by Application (2019-2030)
5.1.1 Global Postoperative Pain Therapeutics Sales by Application (2019-2024)
5.1.2 Global Postoperative Pain Therapeutics Sales by Application (2025-2030)
5.1.3 Global Postoperative Pain Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Postoperative Pain Therapeutics Revenue by Application (2019-2030)
5.2.1 Global Postoperative Pain Therapeutics Revenue by Application (2019-2024)
5.2.2 Global Postoperative Pain Therapeutics Revenue by Application (2025-2030)
5.2.3 Global Postoperative Pain Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Postoperative Pain Therapeutics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 Pacira BioSciences
6.2.1 Pacira BioSciences Corporation Information
6.2.2 Pacira BioSciences Description and Business Overview
6.2.3 Pacira BioSciences Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pacira BioSciences Postoperative Pain Therapeutics Product Portfolio
6.2.5 Pacira BioSciences Recent Developments/Updates
6.3 Trevena
6.3.1 Trevena Corporation Information
6.3.2 Trevena Description and Business Overview
6.3.3 Trevena Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Trevena Postoperative Pain Therapeutics Product Portfolio
6.3.5 Trevena Recent Developments/Updates
6.4 Heron Therapeutics
6.4.1 Heron Therapeutics Corporation Information
6.4.2 Heron Therapeutics Description and Business Overview
6.4.3 Heron Therapeutics Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Heron Therapeutics Postoperative Pain Therapeutics Product Portfolio
6.4.5 Heron Therapeutics Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Postoperative Pain Therapeutics Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Industries Postoperative Pain Therapeutics Product Portfolio
6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Postoperative Pain Therapeutics Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Camarus
6.8.1 Camarus Corporation Information
6.8.2 Camarus Description and Business Overview
6.8.3 Camarus Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Camarus Postoperative Pain Therapeutics Product Portfolio
6.8.5 Camarus Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lilly Postoperative Pain Therapeutics Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Corporation Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Postoperative Pain Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer AG Postoperative Pain Therapeutics Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Postoperative Pain Therapeutics Industry Chain Analysis
7.2 Postoperative Pain Therapeutics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Postoperative Pain Therapeutics Production Mode & Process
7.4 Postoperative Pain Therapeutics Sales and Marketing
7.4.1 Postoperative Pain Therapeutics Sales Channels
7.4.2 Postoperative Pain Therapeutics Distributors
7.5 Postoperative Pain Therapeutics Customers
8 Postoperative Pain Therapeutics Market Dynamics
8.1 Postoperative Pain Therapeutics Industry Trends
8.2 Postoperative Pain Therapeutics Market Drivers
8.3 Postoperative Pain Therapeutics Market Challenges
8.4 Postoperative Pain Therapeutics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
